Regulus Therapeutics Inc (RGLS)
1.885
-0.12
(-6.22%)
USD |
NASDAQ |
May 21, 16:00
1.885
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Free Cash Flow: -28.24M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -28.24M |
| December 31, 2023 | -27.38M |
| September 30, 2023 | -27.50M |
| June 30, 2023 | -27.42M |
| March 31, 2023 | -27.52M |
| December 31, 2022 | -25.89M |
| September 30, 2022 | -27.44M |
| June 30, 2022 | -26.30M |
| March 31, 2022 | -25.10M |
| December 31, 2021 | -24.38M |
| September 30, 2021 | -13.32M |
| June 30, 2021 | -12.24M |
| March 31, 2021 | -12.31M |
| December 31, 2020 | -12.55M |
| September 30, 2020 | -20.77M |
| June 30, 2020 | -21.16M |
| March 31, 2020 | -21.63M |
| December 31, 2019 | -20.06M |
| September 30, 2019 | -19.05M |
| June 30, 2019 | -25.62M |
| March 31, 2019 | -32.13M |
| December 31, 2018 | -43.30M |
| September 30, 2018 | -50.46M |
| Date | Value |
|---|---|
| June 30, 2018 | -50.76M |
| March 31, 2018 | -55.86M |
| December 31, 2017 | -59.09M |
| September 30, 2017 | -63.18M |
| June 30, 2017 | -67.42M |
| March 31, 2017 | -67.35M |
| December 31, 2016 | -57.85M |
| September 30, 2016 | -60.13M |
| June 30, 2016 | -56.42M |
| March 31, 2016 | -49.13M |
| December 31, 2015 | -51.29M |
| September 30, 2015 | -45.42M |
| June 30, 2015 | -42.35M |
| March 31, 2015 | -43.11M |
| December 31, 2014 | -40.72M |
| September 30, 2014 | -38.52M |
| June 30, 2014 | -34.03M |
| March 31, 2014 | -31.01M |
| December 31, 2013 | -29.16M |
| September 30, 2013 | -19.34M |
| June 30, 2013 | -14.44M |
| March 31, 2013 | -11.90M |
| December 31, 2012 | -10.15M |
Free Cash Flow Range, Past 5 Years
-28.24M
Minimum
Mar 2024
-12.24M
Maximum
Jun 2021
-22.29M
Average
-24.74M
Median
Free Cash Flow Benchmarks
| ACADIA Pharmaceuticals Inc | 63.71M |
| Cassava Sciences Inc | -87.90M |
| Vertex Pharmaceuticals Inc | 3.479B |
| Cormedix Inc | -45.70M |
| Oragenics Inc | -8.246M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -8.742M |
| Cash from Investing (Quarterly) | -78.54M |
| Cash from Financing (Quarterly) | 93.10M |
| Free Cash Flow Per Share (Quarterly) | -0.3121 |
| Free Cash Flow Yield | -68.31% |